Tokyo (JCN) Jan 11, 2006 - Sanwa Kagaku Kenkyusho will begin distributing SEIBULE Tablet 25mg/50mg/75mg, its proprietary ethical drug for treating diabetes, on January 11. The new product, which is made of miglitol, is indicated for reducing postprandial blood glucose levels in type 2 diabetics.
